ABOS: Acumen Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ABOS: Acumen Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 152.00
Enterprise Value ($M) 148.49
Book Value ($M) 217.20
Book Value / Share 3.62
Price / Book 0.70
NCAV ($M) 157.86
NCAV / Share 2.63
Price / NCAV 0.96

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 10.42
Current Ratio 10.43

Balance Sheet (mrq) ($M)
Current Assets 207.63
Assets 266.98
Liabilities 49.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Deep Track Capital, LP 0.00 -100.00
02-06 13G Franklin Resources Inc 5.80
01-24 13G/A Murray James B Jr 4.60 3.87

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-14 54,630 180,397 30.28
2024-11-13 58,785 171,867 34.20
2024-11-12 160,344 404,790 39.61
2024-11-11 55,709 176,801 31.51

(click for more detail)

Similar Companies
ABCL – AbCellera Biologics Inc. ABUS – Arbutus Biopharma Corporation
ACAD – ACADIA Pharmaceuticals Inc.


Financial data and stock pages provided by
Fintel.io